• Français (FR)

CESTI

  • CESTI
    • Presentation
    • Mission & objectives
    • Governance
    • Foundings members
    • Find Us
  • Research
    • Mechanisms of acute and chronic grafts loss
    • Innovative ways of Immuno-Intervention
    • Gene & Cell therapy programs
    • Scientific publications
  • Platforms
    • CESTI Platforms
    • Associated CESTI Platforms
  • Deliverables
  • Interactions

Gene & Cell therapy programs

Harnessing liver's immune privilege for the induction of tolerance to allogeneic transplantation - Dr. Sophie Conchon
Gene therapy for a common recessive form of retinitis pigmentosa - Dr. Fabienne Rolling, Dr. Philippe Moullier
Controlling immunity against vectors and therapeutic genes after gene transfer to the skeletal muscle - Dr. Philippe Moullier, Dr. Oumeya Adjali
Breakthrough delivery systems for nucleic-acids based vaccines - Dr. Bruno Pitard
Cell xenotherapy for type 1 diabetes - Dr. Jean-Marie Bach
New rodent model with both humanized liver and humanized immune system to model human allogeneic immune response - Dr. Tuan Nguyen
MuStem cells and Duchenne Muscular Dystrophy therapy - Dr. Karl Rouger
Mesenchymal stromal cells, Inflammation and Immunity - Dr. Karin Tarte
Development of a biological cutaneous dressing using secure banks of fetal allogeneic skin cells - Pr. Brigitte Dréno

Research

  • Mechanisms of acute and chronic grafts loss
  • Innovative ways of Immuno-Intervention
  • Gene & Cell therapy programs
  • Scientific publications

Partners

                 
The French National Research Agency Investments for the Future  Nantes University Nantes University Hospital The French Health and Medical Research Institute Pays de la Loire Region Nantes Metropole  The Nantes Atlantic College of Veterinary Medicine, Food Sciences and Engineering & Nutrition - ONIRIS - Nantes Veterinary School  The French competitivity Cluster “Atlanpole Biotherapies”  Rennes University Hospital